Johnson & Johnson (JNJ) 100.00 $JNJ
1 Hot Biotech Stock + 1 Extremely Strange Call = 10% Plunge
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon May 05, 5:30PM CDT
Friday's bad market for Pharmacyclics wasn't the outcome of a poor quarter. In fact, just looking at the 1st quarter sales of Imbruvica, the blood cancer drug it shares with Johnson & Johnson , there is no reason to think it won't fulfill...
Final Glance: Pharmaceuticals companies
AP - Mon May 05, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon May 05, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Johnson & Johnson Announces U.S. "Champions of Care" Program Finalists as Part of 2014 FIFA World Cup Brazil(TM) Sponsorship
PR Newswire - Mon May 05, 2:54PM CDT
Johnson & Johnson, the Official Healthcare Sponsor of the 2014 FIFA World Cup Brazil(TM), announced today the six finalists for the US Champions of Care program, which was created to shine a spotlight on people who go above and beyond to do extraordinary things in caring for others.
Midday Glance: Pharmaceuticals companies
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Interesting January 2015 Stock Options For JNJ
at The Street - Mon May 05, 11:15AM CDT
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the...
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 05, 10:30AM CDT
Pharmacyclics' (PCYC) first quarter earnings of 23 cents per share blew past the Zacks Consensus Estimate of 9 cents per share.
Vertex Down on Wider-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 05, 10:20AM CDT
Vertex Pharmaceuticals Inc. (VRTX) reported first quarter 2014 loss of 85 cents per share (including stock-based compensation expense).
Early Glance: Pharmaceuticals companies
AP - Mon May 05, 9:37AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon May 05, 9:37AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Stock Movements, Senior Level Appointments, Quarterly Earnings Release, New Agreement, and Drug Approvals - Analyst Notes on Sallie Mae, Visa, MasterCard, Willis and Johnson & Johnson
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding SLM Corporation (NASDAQ: SLM), Visa Inc. (NYSE: V), MasterCard Inc. (NYSE: MA), Willis Group Holdings PLC (NYSE: WSH) and Johnson & Johnson (NYSE: JNJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2019-100free.
A White Knight Riding to the Rescue?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat May 03, 9:36AM CDT
Valeant Pharmaceuticals has teamed up with Pershing Capital, which owns nearly 10% of Allergan , in an effort to acquire the remaining 90% of the company. However, as Allergan looks to have an excellent growth runway ahead, there may be a number...
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence...
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems...
Johnson & Johnson Set to Possibly Rebound After Yesterday's Selloff of 1.21%
Comtex SmarTrend(R) - Fri May 02, 3:43PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $98.88 to a high of $100.38. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $99.93 on volume of 8.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why Pharmacyclics, Inc. Shares Stumbled Out of the Gate
Sean Williams, The Motley Fool - Motley Fool - Fri May 02, 1:19PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Pharmacyclics , a biopharmaceutical...
1 Hot Biotech Stock + 1 Extremely Strange Call = 10% Plunge
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon May 05, 5:30PM CDT
Friday's bad market for Pharmacyclics wasn't the outcome of a poor quarter. In fact, just looking at the 1st quarter sales of Imbruvica, the blood cancer drug it shares with Johnson & Johnson , there is no reason to think it won't fulfill...
Final Glance: Pharmaceuticals companies
AP - Mon May 05, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon May 05, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Johnson & Johnson Announces U.S. "Champions of Care" Program Finalists as Part of 2014 FIFA World Cup Brazil(TM) Sponsorship
PR Newswire - Mon May 05, 2:54PM CDT
Johnson & Johnson, the Official Healthcare Sponsor of the 2014 FIFA World Cup Brazil(TM), announced today the six finalists for the US Champions of Care program, which was created to shine a spotlight on people who go above and beyond to do extraordinary things in caring for others.
Midday Glance: Pharmaceuticals companies
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Interesting January 2015 Stock Options For JNJ
at The Street - Mon May 05, 11:15AM CDT
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the...
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 05, 10:30AM CDT
Pharmacyclics' (PCYC) first quarter earnings of 23 cents per share blew past the Zacks Consensus Estimate of 9 cents per share.
Vertex Down on Wider-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 05, 10:20AM CDT
Vertex Pharmaceuticals Inc. (VRTX) reported first quarter 2014 loss of 85 cents per share (including stock-based compensation expense).
Early Glance: Pharmaceuticals companies
AP - Mon May 05, 9:37AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon May 05, 9:37AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Stock Movements, Senior Level Appointments, Quarterly Earnings Release, New Agreement, and Drug Approvals - Analyst Notes on Sallie Mae, Visa, MasterCard, Willis and Johnson & Johnson
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding SLM Corporation (NASDAQ: SLM), Visa Inc. (NYSE: V), MasterCard Inc. (NYSE: MA), Willis Group Holdings PLC (NYSE: WSH) and Johnson & Johnson (NYSE: JNJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2019-100free.
A White Knight Riding to the Rescue?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat May 03, 9:36AM CDT
Valeant Pharmaceuticals has teamed up with Pershing Capital, which owns nearly 10% of Allergan , in an effort to acquire the remaining 90% of the company. However, as Allergan looks to have an excellent growth runway ahead, there may be a number...
The Dow Misses a New Record as Merck, Pfizer, and J&J Lag
Dan Caplinger, The Motley Fool - Motley Fool - Fri May 02, 8:05PM CDT
After climbing to potential new-record levels at the open, the Dow Jones Industrials closed down almost 46 points on Friday, with trouble in Ukraine heating up and prompting an emergency meeting of the U.N. Security Council in response to violence...
Medical Devices Face Onslaught Of Pricing Pressure
at Investor's Business Daily - Fri May 02, 4:26PM CDT
Makers of medical devices are coming under increasing pressure, owing to a fundamental power shift in American medicine favoring insurance companies, hospitals and their patients. The change, according to Moty Avisar, president of medical systems...
Johnson & Johnson Set to Possibly Rebound After Yesterday's Selloff of 1.21%
Comtex SmarTrend(R) - Fri May 02, 3:43PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $98.88 to a high of $100.38. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $99.93 on volume of 8.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why Pharmacyclics, Inc. Shares Stumbled Out of the Gate
Sean Williams, The Motley Fool - Motley Fool - Fri May 02, 1:19PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Pharmacyclics , a biopharmaceutical...
